"Gold Nanoparticles Show Promise in Reversing Parkinson's Symptoms"

Scientists are exploring the potential of an experimental oral drug, CNM-Au8, containing gold nanoparticles to treat neurodegenerative diseases like Parkinson's and multiple sclerosis. In phase II clinical trials, the drug showed promise in boosting brain metabolism and improving energy supply to neurons. Patients with Parkinson's and MS experienced an increase in their NAD+/NADH ratio, indicating potential reversal of declines in neurodegenerative diseases. The drug's ability to penetrate the blood-brain barrier and its low toxicity make it a promising candidate for further development as a disease-modifying agent.